ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Real-Time Data... Are We Fixing The Right Bottleneck (Or Any For That Matter)?

  Real-time data streaming to regulators is a bold step, but true clinical acceleration requires solving site-level bottlenecks and data silos to reduce the administrative burden on research.

• How Analytics Are Shaping The Future Of Clinical Trial Risk Management

  Explore how analytics are revolutionizing clinical trial risk management and shaping the future of risk mitigation.

• Data Integrity In Clinical Trials: The Role Of Advanced EDC Systems

  How can Electronic Data Capture (EDC) tools streamline your data collection process and help you manage the increasing complexity and data?

• The Benefits Of Next-Generation SAAS Have Arrived

  See how life science companies are using software as a service (SaaS) to bring new benefits to study startup, data collection, and more with this short blog.

• Navigating The eCOA Vendor Landscape In 2025

  This guide offers a clear-eyed perspective on the current eCOA landscape, providing sponsors with actionable guidance to make confident, informed vendor choices.

• Your CRAs Aren't Monitoring. They're Managing Workarounds.

  CRA productivity rises when monitoring shifts from manual tasks to streamlined access, standardized workflows, and proactive oversight — freeing time for engagement, data quality, and patient safety.

• Empowering Freenome: Large-Scale Data Quality And Compliance

  Delve into five ways this biotech company was able to successfully deliver data quality and compliance for large-scale trials while developing next-generation blood tests for early cancer detection.

• The Strategic Case For RTSM in Phase 1 Trials

  Phase 1 trials demand precision and speed. RTSM delivers real-time control over enrollment, dosing, and supply, reducing risk and enabling adaptive strategies that keep timelines on track.

• What Happened At ASCO 2024

  Discover our associates' insights on the key developments from ASCO 2024 that are set to shape the future of cancer care and patient outcomes.

• Cagey Sponsors, Defensive Vendors: Observations On How Transparency Breaks Down

  Discover how hidden operational uncertainties trigger defensive pricing and scope disputes—and how early transparency builds stable, high-performing research partnerships.